tiprankstipranks
Trending News
More News >
Fennec Pharmaceuticals (TSE:FRX)
TSX:FRX
Canadian Market
Advertisement

Fennec Pharmaceuticals (FRX) Ratios

Compare
18 Followers

Fennec Pharmaceuticals Ratios

TSE:FRX's free cash flow for Q4 2024 was $0.92. For the 2024 fiscal year, TSE:FRX's free cash flow was decreased by $ and operating cash flow was $-0.08. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
5.13 3.56 5.80 13.54 13.39
Quick Ratio
4.97 3.27 5.67 13.54 13.39
Cash Ratio
2.71 1.76 5.16 12.76 12.93
Solvency Ratio
-0.32 -0.41 -0.80 -0.04 -7.46
Operating Cash Flow Ratio
-1.92 -2.27 -3.92 -8.60 -6.64
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ -937.00K$ -11.63M$ -2.78M$ 15.74M$ 29.07M
Leverage Ratios
Debt-to-Assets Ratio
0.00 1.15 0.92 0.22 0.00
Debt-to-Equity Ratio
0.00 -2.66 -9.69 0.32 0.00
Debt-to-Capital Ratio
0.00 1.60 1.12 0.24 0.00
Long-Term Debt-to-Capital Ratio
0.00 1.60 1.12 0.24 0.00
Financial Leverage Ratio
18.63 -2.31 -10.49 1.42 1.08
Debt Service Coverage Ratio
-4.46 -3.64 -23.25 -137.26 -1.98K
Interest Coverage Ratio
-4.91 -3.76 -23.10 -136.69 -1.99K
Debt to Market Cap
0.00 0.10 0.10 0.04 0.00
Interest Debt Per Share
0.09 1.29 0.98 0.20 <0.01
Net Debt to EBITDA
2.08 -1.43 -0.05 0.94 1.69
Profitability Margins
Gross Profit Margin
90.27%94.08%94.40%0.00%100.00%
EBIT Margin
-32.84%-59.53%-1481.17%0.00%-10647.06%
EBITDA Margin
-35.21%-58.18%-1471.47%0.00%-10579.41%
Operating Profit Margin
-38.76%-60.09%-1471.60%0.00%-10520.59%
Pretax Profit Margin
-45.52%-75.50%-1544.89%0.00%-10652.35%
Net Profit Margin
-45.52%-75.50%-1554.46%0.00%-10542.35%
Continuous Operations Profit Margin
-41.75%-75.50%-1544.89%0.00%-10652.35%
Net Income Per EBT
100.00%100.00%100.62%100.63%98.97%
EBT Per EBIT
117.43%125.64%104.98%100.71%101.25%
Return on Assets (ROA)
-30.33%-59.73%-88.57%-77.88%-57.05%
Return on Equity (ROE)
589.85%138.06%928.80%-110.68%-61.65%
Return on Capital Employed (ROCE)
-31.51%-66.13%-101.16%-82.96%-61.52%
Return on Invested Capital (ROIC)
-31.51%-66.06%-101.79%-83.49%-60.89%
Return on Tangible Assets
-30.33%-59.73%-88.57%-77.88%-57.05%
Earnings Yield
-5.86%-5.28%-9.40%-15.23%-10.60%
Efficiency Ratios
Receivables Turnover
1.71 2.41 0.99 0.00 0.00
Payables Turnover
0.57 0.33 0.04 0.00 0.00
Inventory Turnover
2.14 0.58 0.15 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.67 0.79 0.06 0.00 <0.01
Working Capital Turnover Ratio
0.86 1.03 0.07 0.00 <0.01
Cash Conversion Cycle
-256.98 -318.86 -7.33K 0.00 0.00
Days of Sales Outstanding
213.51 151.38 367.38 0.00 0.00
Days of Inventory Outstanding
170.42 625.05 2.44K 0.00 0.00
Days of Payables Outstanding
640.90 1.10K 10.14K 0.00 0.00
Operating Cycle
383.93 776.43 2.81K 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-0.58 -0.65 -0.69 -0.55 -0.66
Free Cash Flow Per Share
-0.58 -0.65 -0.69 -0.55 -0.66
CapEx Per Share
0.00 0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
0.00 -0.55 -0.73 -2.85 0.00
Operating Cash Flow to Sales Ratio
-0.52 -0.81 -11.76 0.00 -91.74
Free Cash Flow Yield
-6.67%-5.64%-7.12%-12.41%-9.22%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-16.88 -18.93 -10.63 -6.57 -9.44
Price-to-Sales (P/S) Ratio
7.70 14.29 165.29 0.00 994.71
Price-to-Book (P/B) Ratio
95.38 -26.13 -98.76 7.27 5.82
Price-to-Free Cash Flow (P/FCF) Ratio
-14.83 -17.72 -14.05 -8.06 -10.84
Price-to-Operating Cash Flow Ratio
-14.81 -17.72 -14.05 -8.06 -10.84
Price-to-Earnings Growth (PEG) Ratio
3.19 0.56 -0.30 0.55 -0.46
Price-to-Fair Value
95.38 -26.13 -98.76 7.27 5.82
Enterprise Value Multiple
-19.78 -26.00 -11.28 -5.73 -7.72
Enterprise Value
217.88M 321.41M 254.85M 98.51M 138.76M
EV to EBITDA
-20.02 -26.00 -11.28 -5.73 -7.72
EV to Sales
7.05 15.12 166.03 0.00 816.21
EV to Free Cash Flow
-13.58 -18.75 -14.11 -6.93 -8.90
EV to Operating Cash Flow
-13.58 -18.75 -14.11 -6.93 -8.90
Tangible Book Value Per Share
0.09 -0.44 -0.10 0.61 1.23
Shareholders’ Equity Per Share
0.09 -0.44 -0.10 0.61 1.23
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 >-0.01 >-0.01 0.01
Revenue Per Share
1.12 0.80 0.06 0.00 <0.01
Net Income Per Share
-0.51 -0.60 -0.91 -0.67 -0.76
Tax Burden
1.00 1.00 1.01 1.01 0.99
Interest Burden
1.39 1.27 1.04 1.01 1.00
Research & Development to Revenue
0.01 <0.01 2.30 0.00 30.03
SG&A to Revenue
0.75 0.97 11.55 0.00 76.18
Stock-Based Compensation to Revenue
0.15 0.25 2.75 0.00 16.91
Income Quality
1.12 1.07 0.76 0.82 0.86
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis